11/6/2023 | CLHY | Market Commentary: Amneal extended loan bid below OID; Veritiv, Buckeye Partners pricing guidance surfaces
|
11/6/2023 | BK | Market Commentary: Amneal extended loan bid below OID; Veritiv, Buckeye Partners pricing guidance surfaces
|
11/6/2023 | BK | Amneal Pharmaceuticals sets extended term loan size at $2.35 billion
|
11/2/2023 | CLHY | Market Commentary: Six Flags better bid with Cedar Fair news; Hilton, Amneal Pharmaceuticals changes surface
|
11/2/2023 | BK | Amneal lifts spread on $2.54 billion term loan to SOFR plus 550 bps
|
10/24/2023 | BK | Amneal Pharmaceuticals to launch $2.54 billion term loan on Wednesday
|
5/22/2023 | BK | Amneal Pharmaceuticals seeks amendment to shift term loan to SOFR
|
6/3/2022 | BK | Amneal Pharmaceuticals gets $350 million refinanced five-year revolver
|
2/4/2020 | BK | Amneal units obtain $180 million term loan, $30 million revolver
|
12/10/2019 | BK | Amneal subsidiary plans $180 million term loan for AvKARE purchase
|
6/5/2018 | CVLM | Impax Laboratories gets tenders of 99.9% of 2% convertibles due 2022
|
5/7/2018 | BK | Amneal enters into $500 million asset-based revolving credit facility
|
5/7/2018 | CV | Impax adds Amneal under 2% convertibles, amends conversion right
|
3/23/2018 | BK | Market Commentary: EG Group, INAP, Mediacom, Pharmaceutical Product, Las Vegas Sands, Alkermes break
|
3/23/2018 | CLHY | Market Commentary: EG Group, INAP, Mediacom, Pharmaceutical Product, Las Vegas Sands, Alkermes break
|
3/23/2018 | BK | Amneal widens $2.7 billion term loan B pricing to Libor plus 350 bps
|
3/5/2018 | BK | Market Commentary: Doosan Bobcat, Delos Finance, Openlink Financial break; Genex Services revises deal
|
3/5/2018 | CLHY | Market Commentary: Doosan Bobcat, Delos Finance, Openlink Financial break; Genex Services revises deal
|
3/5/2018 | BK | Amneal Pharmaceuticals to launch $2.7 billion term loan B Wednesday
|
10/17/2017 | BK | Amneal Pharmaceuticals plans new financing for Impax purchase
|